Jeli pacjent by ju leczony analogiem GLP-1, powinien przygotowa nazw preparatu, dawk, dat rozpoczcia terapii, schemat zwikszania dawki, aktualn mas ciaa, zmian masy ciaa w czasie oraz opis dziaa niepodanych
To meet demand, both Lilly and Novo look to expand supply capacity of their GLP-1 portfolios
Heart Failure-Dominant Phenotype SGLT2is are foundational in individuals with HF-dominant disease, regardless of diabetes status or ejection fraction
Simple adjustments like eating four or five smaller meals throughout the day rather than the standard three larger meals may help avoid overwhelming your stomach
However, another study demonstrates that IGF-IR overexpression is essential for leukemia-initiating cell activity in T-ALL [15]